Biography:

Dr. Camille Balanca studied Oncology at the Paul Sabatier University in Toulouse, France and graduated in 2017. She then joined the research group of Prof. Maha Ayyoub at the Cancer Research Center of Toulouse, France to study T cell exhaustion in cancer patients and received her PhD degree in 2021. Following her doctorate, she undertook postdoctoral research in Ira Mellman’s lab at Genentech, South San Francisco, CA where she focused on exploring cancer vaccines in preclinical models.